↑ Rising
Business
Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
A fatal infection in Bristol Myers’ autoimmune CAR‑T trial upends expectations for a promising multiple‑sclerosis therapy
Autoimmune Therapy
3 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Autoimmune Therapy
This hub groups 3 separate news trends connected to Autoimmune Therapy, spanning August 28, 2026 through October 24, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 21 article observations and 21 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
Novartis and Bristol Myers have halted autoimmune CAR-T trials after three patient deaths.
◼ Archived
Health
🔮 fades ✓
Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
A cancer therapy has shown promise in treating severe rheumatoid arthritis, offering new hope to patients.